Shopping Cart
Remove All
Your shopping cart is currently empty
Maplirpacept (TTI-622; PF-07901801) is a fusion protein composed of the CD47 binding domain of human SIRPα linked to the Fc region of human IgG4. It enhances phagocytosis by inhibiting CD47.

| Description | Maplirpacept (TTI-622; PF-07901801) is a fusion protein composed of the CD47 binding domain of human SIRPα linked to the Fc region of human IgG4. It enhances phagocytosis by inhibiting CD47. |
| Synonyms | TTI-622, PF-07901801 |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 2631667-06-4 |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.